SuperMush, a wellness brand creating generation functional products built on research-backed ingredients, including nootropics, adaptogens and functional mushrooms, has raised $3 million in a Series A funding round led by NDude, a healthcare and wellness focused investment firm.
The startup will use the raised capital for product expansion, deepen investment in high-efficacy formulations, and strengthen the team and infrastructure needed to reach more customers.
Founded in 2022 by Alli Schaper and Brian Friedman, SuperMush operates across retail and direct-to-consumer channels. The startup said its products are available in more than 2,000 stores across the US, including over 1,000 Target locations and Sprouts stores, alongside its online business.
Over the past year, ot expanded its presence to more than 1,000 Target stores while continuing to sell through its website and Amazon. It also expanded its product range with the launch of Shilajit, Creatine and Lion's Mane gummies.
“NDude Labs invests in differentiated, science-backed products and founders with the vision and grit to build enduring brands,” said Vikram Sehgal, COO at NDude Labs.
“Our investment in SuperMush provides the capital to accelerate the company’s growth, along with the talent, systems and support needed to scale the business thoughtfully and sustainably.”
“We are so excited to be partnering with NDude Labs for this next phase of our evolution,” said Alli Schaper, co-founder and CEO of SuperMush. “Over the last few years, we’ve built an incredible community, products and brand presence grounded in our mission to bring the power of functional mushrooms to the world.
Source link







